25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Reliability and validity of the Japanese version of the Ocular Surface Disease Index for dry eye disease

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          The Ocular Surface Disease Index (OSDI) questionnaire is widely used to evaluate subjective symptoms of dry eye disease (DED) as a primary diagnostic criterion. This study aimed to develop a Japanese version of the OSDI (J-OSDI) and assess its reliability and validity.

          Design and setting

          Hospital-based cross-sectional observational study.

          Participants

          A total of 209 patients recruited from the Department of Ophthalmology at Juntendo University Hospital.

          Methods

          We translated and culturally adapted the OSDI into Japanese. The J-OSDI was then assessed for internal consistency, reliability and validity. We also evaluated the optimal cut-off value to suspect DED using an area under the receiver operating characteristic curve (AUC) analysis.

          Primary outcome measures

          Internal consistency, test–retest reliability and discriminant validity of the J-OSDI as well as the optimal cut-off value to suspect DED.

          Results

          Of the participants, 152 had DED and 57 did not. The J-OSDI total score showed good internal consistency (Cronbach's alpha=0.884), test–retest reliability (interclass correlation coefficient=0.910) and discriminant validity by known-group comparisons (non-DED, 19.4±16.0; DED, 37.7±22.2; p<0.001). Factor validity was used to confirm three subscales within the J-OSDI according to the original version of the questionnaire. Concurrent validity was assessed by Pearson correlation analysis, and the J-OSDI total score showed a strong positive correlation with the Dry Eye-Related Quality-of-Life Score (γ=0.829). The optimal cut-off value of the J-OSDI total score was 36.3 (AUC=0.744).

          Conclusions

          The J-OSDI was developed and validated in terms of reliability and validity as an effective tool for DED assessment and monitoring in the Japanese population.

          Related collections

          Most cited references18

          • Record: found
          • Abstract: found
          • Article: not found

          Coefficient alpha and the internal structure of tests

          Psychometrika, 16(3), 297-334
            • Record: found
            • Abstract: found
            • Article: not found

            The economic burden of dry eye disease in the United States: a decision tree analysis.

            The aim of this study was to estimate both the direct and indirect annual cost of managing dry eye disease (DED) in the United States from a societal and a payer's perspective. A decision analytic model was developed to estimate the annual cost for managing a cohort of patients with dry eye with differing severity of symptoms and treatment. The direct costs included ocular lubricants, cyclosporine, punctal plugs, physician visits, and nutritional supplements. The indirect costs were measured as the productivity loss because of absenteeism and presenteeism. The model was populated with data that were obtained from surveys that were completed by dry eye sufferers who were recruited from online databases. Sensitivity analyses were employed to evaluate the impact of changes in parameters on the estimation of costs. All costs were converted to 2008 US dollars. Survey data were collected from 2171 respondents with DED. Our analysis indicated that the average annual cost of managing a patient with dry eye at $783 (variation, $757-$809) from the payers' perspective. When adjusted to the prevalence of DED nationwide, the overall burden of DED for the US healthcare system would be $3.84 billion. From a societal perspective, the average cost of managing DED was estimated to be $11,302 per patient and $55.4 billion to the US society overall. DED poses a substantial economic burden on the payer and on the society. These findings may provide valuable information for health plans or employers regarding budget estimation.
              • Record: found
              • Abstract: not found
              • Article: not found

              Reproducibility and responsiveness of health status measures statistics and strategies for evaluation

                Author and article information

                Journal
                BMJ Open
                BMJ Open
                bmjopen
                bmjopen
                BMJ Open
                BMJ Publishing Group (BMA House, Tavistock Square, London, WC1H 9JR )
                2044-6055
                2019
                25 November 2019
                : 9
                : 11
                : e033940
                Affiliations
                [1 ] departmentDepartment of Hospital Administration , Juntendo University Graduate School of Medicine , Bunkyo-ku, Tokyo, Japan
                [2 ] departmentDepartment of Ophthalmology , Juntendo University Faculty of Medicine , Bunkyo-ku, Tokyo, Japan
                [3 ] departmentDepartment of Strategic Operating Room Management and Improvement , Juntendo University Faculty of Medicine , Bunkyo-ku, Tokyo, Japan
                [4 ] departmentDepartment of Medical Technology Center , Juntendo University Faculty of Medicine , Bunkyo-ku, Tokyo, Japan
                [5 ] departmentPrecision Health, Department of Bioengineering , Graduate School of Engineering, The University of Tokyo , Bunkyo-ku, Tokyo, Japan
                [6 ] departmentDepartment of Health Services Research , University of Tsukuba , Tsukuba, Ibaraki, Japan
                [7 ] departmentDepartment of Ophthalmology , Juntendo University Graduate School of Medicine , Bunkyo-ku, Tokyo, Japan
                [8 ] departmentSchool of Cultural and Creative Studies , Aoyama Gakuin University , Shibuya-ku, Tokyo, Japan
                Author notes
                [Correspondence to ] Dr Takenori Inomata; tinoma@ 123456juntendo.ac.jp
                Author information
                http://orcid.org/0000-0003-3435-1055
                Article
                bmjopen-2019-033940
                10.1136/bmjopen-2019-033940
                6886996
                31772113
                929904bb-3ad8-422b-9d87-bf6c935cbe70
                © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

                This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.

                History
                : 29 August 2019
                : 10 October 2019
                : 01 November 2019
                Categories
                Ophthalmology
                Original Research
                1506
                1718
                Custom metadata
                unlocked

                Medicine
                dry eye disease,ocular surface disease index,osdi,reliability,validity
                Medicine
                dry eye disease, ocular surface disease index, osdi, reliability, validity

                Comments

                Comment on this article

                Related Documents Log